Mtv11, Mtv13, Mtv14, and Mtv17 positive), C57L (Mtv8, Mtv9, Mtv11, Mtv17, and Mtv29 positive), LAF 1 (Mtv6, Mtv8, Mtv9, Mtv11, Mtv13, Mtv17, Mtv23, and Mtv29 positive) MA/MyJ (Mtv8, Mtv9, Mtv17, Mtv29 and Mtv43 positive), and female NOD mice (Mtv3 and Mtv17 positive; Ref. 14, 15) were purchased from The Jackson Laboratory (Bar Harbor, ME). (SJL ϫ SWR)F 1 mice were bred in the animal facilities of New York University School of Medicine (New York, NY). Lymphoma cell lines were derived from primary tumors that developed in aging mice of different strains and designated as follows: SJL-derived, cRCS-2, cRCS-3, cNJ117, and cNJ101; C57L-derived, cNJ123 and cNJ120; MA/My derived, cNJ126 and cNJ124. In addition, primary tumors were studied from SW ϫ J-1, lymphomas 326 and 340. The SW ϫ J-1 strain was derived at The Jackson Laboratory, and the mice were generously donated by Dr. W. Beamer. These mice were studied previously for genetic markers (9, 16, 17) . The lymphomas examined here were detected in another study in which the lymphoma incidences of the various SW ϫ J RI mouse strains were examined (W. J. Simmons, N. M. Ponzio, V. K. Tsiagbe, W. Beamer, G. Inghirami, and G. J. Thorbecke, manuscript in preparation). Unlike other SJL-derived lymphomas, NJ101 arose in a 2-year-old SJL mouse that was receiving chronic treatment with anti-CD4 mAb (18) . It differs from other SJL tumors by its phenotype (IgM ϩ ), absence of vSAg29 expression, and an inability to stimulate syngeneic SJL T lymphocytes (2, 3) .
Hybridomas with TCR V␤8.1, TCR V␤8.2, TCR V␤11, TCR V␤12, TCR V␤13, and TCR V␤15 were generously provided by Dr. D. Woodland (St. Jude Children's Research Hospital, Memphis, TN); the hybridoma with TCR V␤17a was kindly provided by Drs. P. Marrack and J. W. Kappler (National Jewish Center of Immunology, Denver, CO); hybridomas with TCR V␤16 were derived in our laboratory (2, 3) .
DNA preparation and PCR
High-m.w. DNA was isolated from cells by using the genomic DNA isolation kit of Promega (Madison, WI) according to the protocol provided by the manufacturer. PCR was performed with reagents provided in the PCR kit from Promega with a DNA thermal cycler 480 (Perkin-Elmer, Foster City, CA). Reaction conditions were as follows: buffer containing 20 mM Tris-HCl, pH 8.4, 2.5 mM MgCl 2 , 50 mM KCl; 30 cycles of 45 s of denaturation at 94°C, annealing for 1 min at 60°C, and extension for 30 s at 72°C, with a final extension step for 10 min at 72°C. Some PCR products were cloned into the PCR TM 2.1 vector (Invitrogen, San Diego, CA) and sequenced.
RNA preparation and RT-PCR
Total RNA was isolated from cells by using RNA Stat-60 (Tel Test, Friendswood, TX). Pretreatment of RNA with DNase 1 was performed to exclude DNA contamination. cDNA was synthesized by using the Superscript preamplification system (Life Technologies, Gaithersburg, MD). Briefly, 2.5-5 g of total RNA was mixed with 1 l (0.5 g) of oligo(dt) 12-18 and incubated for 10 min at 70°C. The mixture then was placed on ice after addition of 2.5 mM MgCl 2 , 10 mM DTT, 0.5 mM deoxyribonucleotide triphosphate, reverse transcription buffer (1ϫ), and 200 U of Superscript II reverse transcriptase. cDNA synthesis was performed in 20 l at 42°C for 50 min. The cDNAs were treated with RNase H for 20 min and 2-5 l was used for PCR.
Oligonucleotide primers used for PCR were obtained from Gene Link (Thornwood, NY). Their sequences were: RLTR: 5Ј-CTTACTTAAACCTT  GGGAACCGCAAG-3Ј; R7, 5Ј-CGAAGCCAACGCGACCCCCATGAG-3Ј;  R8, 5Ј-CATTATAGCTCATGCCAAAAGTATC-3Ј; R17, 5Ј-TTATTATAC  CTTATGTCAAAGGTATCC-3Ј; R29, 5Ј-GCAATTTATCCATGCCAAGTT  TACC-3Ј; L1, 5Ј-TATCATCACAAGAGCGGAACGGACTC-3Ј; L2, 5Ј-TA  CAGACCCCATTAGAGTTCTGAC-3Ј; L3, 5Ј-GAGACGAGTCTGCTCCT  CCACGG-3Ј; META-2: 5Ј-GAAGGGGTGATAAAAGGCGTATGTG-3Ј; and  META-3, 5Ј-CCCCTTGGTCAGGGAATGCGCAAGG-3Ј. The positions of these primer sequences within the MMTV genome are indicated in Fig. 1 . The sequence homology between Mtv8 and Mtv11 (15) and between Mtv7 and Mtv43 (19) makes it unlikely that PCR performed with these primers can distinguish between these MMTVs when both are present in the mouse.
Northern blot analysis
The LTR-ORF probe was cloned into pBluescript as described (3, 13) . Plasmid DNA was isolated by using a maxi prep kit purchased from Life Technologies and double digested with EcoRI and BamHI to recover the LTR-ORF fragment, separated through 1% agarose gel. The META probe was prepared from pGEM-3 vector as described in the protocol for RNase protection assay. The META fragment was recovered from the plasmid by double digestion with EcoRI and HindIII and separation through 1% agarose gel. Equal amounts (20 g) of total RNA samples were electrophoresed under denaturing conditions in 1.2% agarose/formaldehyde gels. RNA was transferred onto a nylon membrane ( probe, GT; Bio-Rad, Richmond, CA) and covalently cross-linked to the membrane by UV irradiation. The membrane was prehybridized for 3 h at 42°C in prehybridization/ hybridization solution (50% formamide, 2.5% Denhardt's solution, 6ϫ SSC phosphate/EDTA, 200 g/ml salmon sperm DNA, 1% SDS) followed by overnight hybridization at 42°C with random-primed 32 P-labeled LTR probe. The hybridized membrane was washed three times for 15 min each in 0.1ϫ SSC/0.1% SDS at room temperature followed by a wash for 30 min at 55°C. The washed filter was exposed to x-ray film (Fuji Film, Tokyo, Japan) at Ϫ70°C. To strip the probe, the filter was boiled in 0.5% SDS for 10 min, cooled to room temperature for 10 min, and rinsed in 2ϫ SSC to recharge the membrane. The stripped filter was hybridized with random-primed 32 P-labeled META probe. LTR-ORF-specific oligonucleotide probes, 31 and 30 mers for Mtv29 and Mtv7, respectively, were purchased from Gene Link (Thornwood, NY). Their sequences were as follows: Mtv29 probe, 5Ј-GTAAAGTGCAATT TATCCATGCCAAGTTTAC-3Ј; Mtv7 probe, 5Ј-GATCGAAGCCAACGC GACCCCCATGAGTAT-3Ј. These oligonucleotide probes were 5Ј-end labeled with [␥-32 P]ATP by polynucleotide T4 kinase and used for probing the RNA transcripts. The membranes were prehybridized for 3 h at 55°C in prehybridization/hybridization solution (6ϫ SSC, 10 mM EDTA, pH 7.5, 2ϫ Denhardt's solution, 100 g/ml sheared and denatured salmon sperm DNA, and 1% SDS). This was followed by overnight hybridization at 55°C with 32 P-labeled oligonucleotide probe. The filter was washed twice for 15 min at 45°C in prewarmed 6ϫ SSC/0.1% SDS followed by two washes for10 min in 2ϫ SSC/0.1% SDS at room temp. The filter was exposed to x-ray film at Ϫ70°C.
RNase protection assay
PCR was performed with the META-2 (7136 -7160) and META-3 (7315-7339) primers with SJL liver DNA and the 204-bp product obtained was cloned into the pGEM-3 vector (Promega). The plasmid was linearized with HindIII, and radiolabeled RNA probe representing positions 7136 through 7339 was synthesized by using [ 32 P]UTP and T3 RNA polymerase. The RNase protection assay was performed according to the manufacturer's protocol with the RNase protection kit of BD PharMingen (San Diego, CA). Briefly, 10 -20 g of total RNA was hybridized with 4 ϫ 10 4 cpm of RNA probe overnight at 56°C. Nonhybridized probe was digested with 10 g/ml RNase A and 65 U/ml RNase T1 for 30 min at 30°C. After extraction with phenol-chloroform and ethanol precipitation, the protected RNA fragments were separated on a 6% polyacrylamide/8 M urea gel and then subjected to PhosphorImaging (Molecular Dynamics, Sunnyville, CA).
Preparation of LPS-activated B cells
Spleen cell suspensions at 10 6 cells/ml in 20-ml Falcon flasks were stimulated with 50 g LPS/ml (Escherichia coli 055:B5; Difco Laboratories, Detroit, MI) for 48 h in IMDM (BioWhittaker, Walkersville, MD) containing 10% FCS (Life Technologies) and 0.05 mM 2-ME.
Mixed lymphocyte culture
MLC were prepared in flat-bottom 96-well plates (Costar, Cambridge, MA) in RPMI 1640 medium (Mediatech, Springfield, NJ), supplemented with 10% FCS (HyClone, Logan, UT), 2 mM glutamine, 100 IU/ml penicillin, 100 g/ml streptomycin, and 0.05 mM 2-ME, as described (20) . Responder cells (2 ϫ 10 5 /well) were mixed at various responder/stimulator ratios with ␥-irradiated lymphoma cells (5,000 -15,000 rad) in 0.2 ml. Cultures were incubated for a total of 96 h at 37°C, the last 16 -18 h with 1 Ci 
Stimulation of T cell hybridomas

Results
Characterization of MMTV transcripts in lymphoma cells from different strains
The RT-PCR products from various lymphomas are represented in Table I . Some 3Ј-primers were specific for Mtv29 (R29), for Mtv7 (R7), for Mtv8 (R8), and for Mtv17 (R17), whereas the RLTR represents a common region of the 3Ј LTR sequence (see Fig. 1 ). The 5Ј-primers (L1, L2, and L3) were common for these MMTVs. The results in Table I show that the detected transcripts that initiated in the 5Ј LTR (1.8 kb, detected with L1), for both Mtv29 and Mtv7, were all 0.7 kb longer than would be expected for mRNA encoding a traditional vSAg. In contrast, Mtv8 and Mtv17 each showed typical vSAg 1.1-kb transcripts when L1 was used as the 5Ј-primer. Mtv8 vSAg mRNA was amplified in lymphomas of C57L and MA/My origin, but not in SJL RCS lymphomas nor in lymphomas from SW ϫ J-1 ( Table I) .
As was shown previously for Mtv29 in SJL lymphoma lines (13), the 1.8-kb transcripts in the C57L lymphoma cNJ123.5 and, to a lesser extent, in the MA/My lymphoma NJ126 contain part of the env (Fig. 2, A and B) . The same is true for the 1.8-kb transcripts FIGURE 1. Schematic representation of MMTV provirus. Two MMTV LTRs, consisting of the U3 region containing the RCS-orf, the R and U5 regions, flank the viral structural genes gag, pol, and env. The position of a MMTV-LTR promoter (10, 11, 38) and the META (39, 40) are identified. Also shown are the previously mapped splice donor (SD1) and splice acceptors for regular env (SAenv) and ORF (SAorf) mRNAs. As also shown previously in SJL cells (13) , there is another shortened env mRNAs (2.9 kb) that uses another splicing mechanism and splicing donor site (SD2), but the same SAorf. Moreover, in RCS cells, the novel promoter (META) within the env initiates the expression of endogenous vSAg29 mRNA (1.8 kb) in which there is the same deletion as in the 2.9-kb shortened env transcripts (13) . Base numbering corresponds to the analogous sequence of a milk-transmitted MMTV (41) . The positions of the probes used as well as the forward and reverse primers used for RT-PCR are indicated. 
a L1 hybridizes immediately adjacent to the 5Ј LTR P1 promoter, L2 in the env region upstream from the META initiation site, identified for vSAg29 transcripts, and L3 in the env region immediately downstream from this initiation site. RLTR detects a common, whereas other R primers detect Mtv-specific regions of the 3Ј LTR sequences. Control PCR done without prior reverse transcription were invariably negative.
b The sequence of the 3Ј LTR of Mtv8 is exactly like that of Mtv11; the 3Ј LTR region of Mtv43 is very similar to Mtv7 (19) . c This PCR product was cloned and sequenced; it is encoded by Mtv8 or Mtv11 (not Mtv9). d As the RNase protection assay uses probes for an env region that is quite similar in sequence for all these MMTVs, the META initiation could be for any of the transcripts detected by PCR using L3.
of Mtv7 in the RNA prepared from SW ϫ J-1 lymphomas 326 and 340 (Fig. 2, A and B) . Thus, all the 1.8-kb transcripts in lymphoma cells contain part of the env region, in agreement with initiation in the env rather than in the 5Ј LTR. In contrast, the 1.8-kb band of the RNA from LPS-activated B cell blasts from the Mtv7 ϩ strain, DBA/2, hybridizes with the LTR, but not with the META-env probe (Fig. 2) . The Mtv29-LTR-specific oligonucleotide probe hybridizes with each of the 3 Mtv transcripts in the SJL lymphomas cNJ-117 and cRCS-X and the C57L lymphoma cNJ123.5 (Fig.  2C ), but not with RNA from lymphomas 340 and 326 (not shown), whereas the Mtv7-LTR -specific oligonucleotide probe hybridizes with RNA from the SW ϫ J-1 lymphomas but not with RNA from cRCS-X (Fig. 2D) . Thus, the SW ϫ J-1 lymphomas exhibit the characteristic mRNAs for Mtv7 of 4.1-, 2.9-, and 1.8-kb lengths.
Only RNase protection assays can firmly establish the presence of transcripts initiating within the env region. This assay should show protected fragments of ϳ92 bp, starting at the initiation site at position 7247 (13) and ending at the splice donor site (SD2, 7338; see Fig. 1 ). The protected bands of ϳ204 bp most likely detect env transcripts initiating in the 5Ј LTR. Consistent with the presence of transcripts initiated at position 7247 and spliced at position 7338 is the detection of a 1.1-kb RT-PCR product when the L3 primer is used in combination with either R29 or R7 (Table  I ). The L3 primer binds within the env, downstream from the initiation site of the vSAg mRNA identified for Mtv29 (13) . The unspliced 2.3-kb RT-PCR products, amplified with these primer pairs, contain the complete 3Ј-env region and are not likely to encode the vSAg mRNA.
vSAg mRNA initiating immediately downstream from the META-env region was detected by RNase protection assay (Fig.  3A) .
Of great interest is the use of this META-env initiation site for vSAg transcription in the SW ϫ J-1 lymphomas, 340 (Fig. 3A) and 326, where Mtv7 is the only candidate, as judged by the RT-PCR Probing with the Mtv7-specific oligonucleotide shows that these 1.8-kb transcripts in lymphomas 326 and 340 are produced by Mtv7 (D). The 1.8-kb mRNAs for MMTV-LTR in SJL (cNJ117 and cRCS-X) and C57L (cNJ123.5) lymphomas, hybridize to the Mtv29-specific oligonucleotide probe (C). Specificity of the oligonucleotide probes is shown by the lack of hybridization of RNA from cRCS-X with the Mtv7 oligonucleotide (D) and of RNA from lymphomas 326 and 340 with the Mtv29 oligonucleotide probe (not shown).
FIGURE 3.
RNase protection assay for detection of the META-env initiation site of MMTV transcripts. Aliquots (20 g) of total RNA isolated from the indicated tissues were hybridized in vitro to a labeled RNA probe made by transcribing an RCS cDNA fragment of the sequence 7136 -7339 using [␣-32 P]UTP and T3 RNA polymerase. RNA-RNA hybrids were digested by RNase A and RNase T1, and double-stranded RNase-resistant fragments were separated on a 6% denaturing polyacrylamide sequencing gel. Arrows indicate the predominant fragments; the lengths of the fragments in nucleotides are indicated. The shorter fragments, seen with RNA from the RCS cell lines cRCS-X and cNJ117 but not NJ101, the C57L cell line, cNJ123.5, the MA/My cell line cNJ126 but not cNJ124, and the RI strain 1 lymphoma 326 (A), are the products associated with the initiation sites within env, the longer ones seen with all the lymphomas and also with RNA from LPS-stimulated B cells (B) are the products protected by the env mRNAs that initiate in the 5Ј LTR. The shorter fragment also is detected in RNA from SJL Peyer's patches (B). products detected. These results clearly indicate that the Mtv7 transcripts in the lymphomas from SW ϫ J-1 mice are analogous to those for Mtv29 in the other lymphoma prone strains studied here.
Characterization of MMTV transcripts in normal B cells
Normal LPS-stimulated B cells never used the env initiation site for Mtv transcripts (Fig. 2B ) and also failed to show a 5Ј LTRinitiated vSAg mRNA, as judged by the RT-PCR product for either Mtv29 or Mtv7 (Table II) . However, the 5Ј LTR-initiated vSAg mRNA (1.1-kb product with L1 and R8) was seen for Mtv8 in LPS-activated B cells from some strains, including DBA/2 and LAF 1 , but not from SJL mice (Table II) . LPS-stimulated B cells from NOD mice showed an unidentified vSAg mRNA that gave a 1.1-kb product on RT-PCR with L3 and RLTR but not with any other reverse primer used, in agreement with the known absence of these MMTVs in this strain. RNase protection assays did not show META env-initiated vSAg transcripts in the RNA from LPS blasts. However, it is interesting that the RNA isolated from Peyer's patches taken from SJL mice aged 3-6 mo, i.e., several months before the typical lymphomas arise in this strain, already showed use of this initiation site (Fig. 3B) . Indeed, although normal lymphoid tissue from other sites in SJL mice, such as spleen and brachial lymph nodes, failed to show these transcripts, Peyer's patches consistently contained them.
Stimulation of syngeneic T cells and of T hybridoma cells by lymphomas from different strains
It was shown previously that unprimed syngeneic T cells are stimulated to proliferate in vitro by ␥-irradiated cells from SJL lymphomas (21, 22) . The same appears to be true for lymphomas of C57L, MA/My, and SW ϫ J-1 origin (Table III) . In the case of SJL lymphomas, this was shown previously to be primarily attributable to the specific stimulation of V␤16 ϩ CD4 ϩ T cells and inhibited by anti-I-A S (2) . Therefore, the ability of C57L and MA/My lymphoma cell lines to stimulate T hybridoma cells bearing various individual V␤-chains in their TCRs was compared with that of the SJL lymphoma line cNJ117 (Table IV) . The in vitro C57L lymphoma line, cNJ123.5, strongly stimulated V␤16 ϩ T hybridomas, as did cNJ117, whereas weak stimulation of the V␤8.1-and the V␤11-bearing T hybridomas by cNJ123.5 also was observed. This finding suggested the presence of vSAg29 in both cNJ117 and cNJ123.5, as well as that of an additional vSAg (Mtv8, Mtv9 and/or Mtv17) in the C57L line that was absent from the SJL line. The MA/My line, cNJ126, also caused detectable stimulation of V␤16 (Table IV) . In view of the expression of mRNA encoding the vSAg7, the ability of the SW ϫ J-1 lymphomas, 326 and 340, to stimulate T hybridomas also was examined. To our surprise we found that among several V␤16 ϩ T hybridoma cells examined, all responded strongly, whereas no stimulation of V␤6 ϩ T cells was obtained (Table IV) . The stimulation of V␤16 ϩ T hybridoma cells by both tumors 326 and 340 was abolished by inclusion of anti-I-A s in the medium. Stimulation of V␤6 ϩ T cells by vSAg7 is known to be strongly dependent on the expression of I-E in the presenting cells (23) . Thus, in view of the fact that SW ϫ J-1 is H2 s , it seemed likely that vSAg7 could not properly be presented by the lymphoma cells (24) . Indeed, when the abilities of LPS-stimulated B cells from SWR (H2 q , Mtv7 ϩ ) and BALB.D2 (H2 d , Mtv7 ϩ ) to stimulate these V␤6 ϩ T hybridoma cells were compared, the SWR cells failed to stimulate (Ͻ 0.15 pg IL-2/ml), whereas the BALB.D2 cells did (1.55 pg IL-2/ml).
Histological features of the SW ϫ J-1 lymphomas
In previous studies, the characteristics of C57L lymphomas were described as very similar to those of SJL primary lymphomas (25) . 
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a ⌬ cpm ϭ cpm of mixed cell cultures Ϫ (cpm (responders) ϩ cpm (stimulators) alone). b These cells were stored frozen. They were thawed and cultured overnight before use as stimulator cells. These cells also strongly stimulated V␤16
ϩ T hybridoma cells.
Like the GC cells from which they are derived, the majority of the primary tumor cells in both SJL and C57L mice also stain with PNA-peroxidase (see also Ref. 1). Therefore, in the present study we examined sections of primary lymphomas from SW ϫ J-1 mice. Again, a very similar morphology and PNA ϩ staining of the tumor cells in both Peyer's patches and mesenteric lymph nodes was seen, entirely comparable to SJL primary lymphomas (Fig. 4) .
Discussion
The present results suggest that expression of META-env-initiated vSAgs encoded by endogenous proviral MMTV is common in the B cell lymphomas of the mouse strains studied here. In the lymphomas originating in Mtv29 ϩ strains, the same vSAg29 that permits SJL lymphomas to stimulate V␤16 ϩ CD4 T cells also is expressed. This observation is supported by the presence of the typical RT-PCR products, use of the env initiation site, and the presence of prominent Mtv29 ϩ 1.8-kb mRNA. However, what is more striking is the observation that the RNA from lymphomas arising in the Mtv29 Ϫ strain, SW ϫ J-1, exhibits identical RT-PCR products, bands hybridizing with the LTR probe on Northern blots, and META-env initiation of Mtv7 ϩ transcripts. These transcripts clearly come from Mtv7, because Mtv8, the only other MMTV in that strain, does not show any RT-PCR products in either of the two lymphomas examined in detail. In a previous study in which a quantitation was made of RsaI-digested RT-PCR products obtained from 5Ј LTR initiated (presumably vSAg) transcripts from Mtv6, Mtv7, Mtv8, and Mtv9 in normal B and T cells from BALB-D2.Mls-1a mice, such transcripts for Mtv7 were found to be highly expressed, particularly in B cells (26) . These LTR-initiated transcripts were thought to encode vSAg7, which is known to be highly expressed in B cells and to cause efficient deletion of Mtv7-responsive V␤6 ϩ , V␤7 ϩ , V␤8.1 ϩ , and V␤9 ϩ T cells in I-E ϩ strains that possess Mtv7 in their genome (27) (28) (29) . However, the present results suggest that LPS-activated B cells do not produce a typical LTR-initiated vSAg for Mtv7, neither in DBA/2 nor in SWR ϫ SJL F 1 B cells, but that they also fail to produce METAenv-initiated transcripts. Therefore, these data do not describe the mRNA encoding the potent vSAg7 in normal B cells. It is likely that the 3Ј-env promoter (P2env), described by Arroyo et al. (30) , is used for vSAg7-encoding transcripts in Mtv7 ϩ LPS blasts. We have not yet examined whether the lymphoma cells studied here also use, in addition to the META, the P2env promoter for vSAg7-encoding transcripts; the prominence in Northern blots of an additional smaller mRNA for Mtv7 in lymphoma 340 suggests this possibility.
The sequence of Mtv29 differs by only a single base in the regions found important for promoter activity in the 3Ј-env of Mtv7 (30) . However, with respect to the possibility that Mtv29 might also use a 3Ј-env promoter and initiation site in LPS blasts, it should be mentioned that in previous studies we have not found syngeneic T cell stimulation by LPS blasts from SJL mice. Moreover, RNA prepared from LPS blasts from SJL mice does not exhibit a 1.8-kb band on probing with an LTR probe, suggesting that, unlike the SJL lymphomas, they fail to express vSAg29 (or vSAg8).
The early histology associated with lymphoma development strongly indicates that SJL lymphomas usually arise in GCs from gut-associated lymphoid tissue, as originally shown by Siegler and Rich (31) and, more recently, by Secord et al. (1) in both normal and Bcl2-transgenic SJL mice. Similarly, all the primary lymphomas from the other strains studied here have a similar morphology, frequently involve Peyer's patches, and are PNA ϩ . If the METAenv-initiated transcripts of Mtv29 play a causal role in the induction of these lymphomas by eliciting a response from V␤16 ϩ CD4 T cells that then causes a chronic stimulation of B cells, one would expect to see such Mtv29 transcripts in Peyer's patches before the lymphomas arise. As shown in the present study (Fig. 3B) , this was indeed found. At this point, it cannot formally be excluded that some lymphoma cells are already present in the Peyer's patches from SJL mice months before significant lymphadenopathy occurs and that this early expression of mRNA for vSAg29 is attributable to them rather than to normal GC cells. In preliminary studies, it was found that Peyer's patch cells from 6-mo-old but not from 3-mo-old SJL mice or from spleen were able to stimulate syngeneic lymph node cells. A more complete study of the stimulatory ability of these cells is underway. We also observed that similar transcripts are found in Peyer's patches from SJL ϫ BALB/c mice that lack V␤16 ϩ T cells and do not develop lymphomas. This suggests that the expression of vSAg29 is in normal B cells from Peyer's patches rather than in lymphoma cells.
Expression of Mtv8 may be regulated differently in various strains of mice (32) . Therefore, it is of interest that Mtv8, which encodes a relatively potent vSAg in many strains, exhibiting vSAg8 transcripts that clearly initiate in the 5Ј LTR, does not exhibit such transcripts in either SJL lymphomas or LPS-induced B cell blasts from SJL mice. Lymphoma cells from the RI strains SW ϫ J-1 also lack such Mtv8 transcripts. In contrast, the lymphoma cell lines derived from MA/My mice clearly exhibit 5Ј LTR-initiated Mtv8 and Mtv17 encoded vSAg transcripts as well as proteins, as shown by their ability to stimulate V␤11, V␤12, and V␤17a bearing T hybridoma cells (15) . These lymphoma cells weakly stimulate V␤16
ϩ T hybridoma cells. In contrast, although both vSAg29 and vSAg8 transcripts also are present in the C57L lymphoma lines, the ability of C57L lymphomas to stimulate V␤16 T hybridomas was significantly greater than their stimulatory activity for V␤8.1-, V␤11-, or V␤12-bearing hybridomas. It is 
a ␥-Irradiated (2 or 20 ϫ 10 3 ; 15,000 or 5,000 rad) cNJ117 or cNJ123.5 cells, respectively, were used to stimulate 10 5 T hybridoma cells for 24 h. Supernatants were harvested and assayed for IL-2 contents by ELISA. No reactivity was seen against cNJ117 or cNJ123.5 cells by T hybrids that express TCR V␤ 1, 2, 3, 4, 10, 14, or 19 (not shown) . The IL-2 contents of supernatants were expressed in pg/ml: -, Ͻ0.02; Ϯ, 0.02-0.05; ϩ, 0.05-0.99; ϩϩ, 1.0 -3.0; ϩϩϩ, Ͼ3.
b Addition of 20 g/ml of an anti-H2-IA S (MK-S4) abolished this response, while control rat Ig had no effect.
possible that MHC class II molecules on the lymphoma cells influence their relative abilities to preferentially present one or another vSAg (33, 34) . It is of great interest that vSAg7 expressed in SW ϫ J-1 lymphomas appears to stimulate V␤16 ϩ T cells. In fact, LPS-stimulated Mtv7 ϩ , I-E ϩ BALB.D2 B cells also were found to stimulate V␤16 ϩ T hybridoma cells, but to a lesser extent than did the lymphoma cells. No previous report of vSAg7 stimulation of V␤16 ϩ T cells has been published, but this result is perhaps not very surprising in view of the fact that a sequence comparison of Mtv29 and Mtv7 shows striking similarities in their 3Ј LTR regions, as well as some significant differences at the 3Ј end (35, 36) .
Whereas the present studies show that all of these lymphomas clearly stimulate syngeneic T cells, the exact nature of the most important T cell subset in this response needs further investigation. This is particularly true for the I-E ϩ MA/My mice, where V␤16 ϩ T cells (our unpublished observation), in addition to V␤5.1 ϩ , V␤11 ϩ , and V␤12 ϩ T cells, are deleted. Moreover, although the need for CD4 T cells in promoting in vivo growth of SJL and C57L lymphomas was clearly established in previous studies (7, 20, 25, 37) , this information is not yet available for the MA/My or the SW ϫ J-1 lymphomas studied here.
It is possible that differential methylation of the LTR and env promoter regions of various Mtvs in different strains, as well as in different tissues of mice, influences the transcription patterns seen in the present study. Preliminary data indicate that significant differences exist between SJL liver and lymphoma DNA in the degree of methylation present in the META-env promoter region of Mtv29 (R. M. Thomas, N. Sen, D. J. Zhang, V. K. Tsiagbe, and G. J. Thorbecke, manuscript in preparation). Further studies are needed to evaluate whether such variations in DNA methylation patterns and/or differences in the presence and recruitment of transcription factors may explain the production of META-env controlled transcripts of Mtv29 in GC cell-derived lymphomas (and perhaps also normal GC cells), but not in LPS-activated B cells. 
